Allison DeAngelis
@ADeAngelis_bio
Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
New email, who dis? I've officially landed at @statnews to cover biopharma startups and venture capital. Send tips/questions to [email protected].
New: AbbVie will pay up to $2.1 billion to acquire Capstan Therapeutics, a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer. statnews.com/2025/06/30/abb… $ABBV
China has one of the lowest rates of obesity in the developed world. So why has it emerged as one of the top locations for testing the scores of new weight loss drugs cropping up every month? I dig into this for @statnews! statnews.com/2025/06/17/wei…
EXCLUSIVE: Sarepta Therapeutics’ $SRPT Duchenne therapy faces ‘arduous’ path back to market, senior FDA official says statnews.com/2025/07/22/fda… via @Jasonmmast and me.
Full story here: statnews.com/2025/07/22/rep…
$REPL rejection follows the rejection of $CAPR and $RARE drugs, and the FDA's actions against $SRPT. CBER Director Vinay Prasad is setting a different tone than his predecessor.
“There is so much hypocrisy.” HHS officials previously said they would release ethics forms for seven new members of the Advisory Committee on Immunization Practices before the group’s first meeting in late June. That deadline came and went. statnews.com/2025/07/09/ken…
Inside the staff exodus and tanking morale that threaten Makary’s FDA by @LizzyLaw_ statnews.com/2025/07/07/fda…
We love an interactive industry Bingo card 🤖🧪 statnews.com/2025/07/02/wha…
#Breaking: The Senate passed a $4.5 trillion tax cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board. trib.al/seVM5yZ
Today is the last day to nominate for #STATWunderkinds! Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program leaders. Have someone in mind? Nominate now: trib.al/DergPEo
.@elaineywchen reported earlier this month that fmr employees feel Novo Nordisk has been overly cautious in the obesity race. Now, Elaine has a great follow-up, where execs acknowledge their past conservative approach and map out the future. statnews.com/2025/06/25/nov…
Top FDA drug regulator tells staff much is still in flux, as she prepares to retire Mike Davis, a psychiatrist who worked in psychedelics, introduced as CDER deputy director statnews.com/2025/06/24/top… via @LizzyLaw_
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, @elaineywchen reports from the ADA conference in Chicago. statnews.com/2025/06/23/amg…
Interesting tidbit, for the times we're in: Vaccine developer Centivax has raised $45 million for a Series A round. The company plans to begin its first clinical trial of a universal flu vaccine early next year.
EXCLUSIVE: STAT takes you inside the FDA to explain the ouster of Nicole Verdun, the agency's chief regulator of cell and gene therapies. Centered around disagreements over Capricor $CAPR Duchenne therapy and Verdun's management style statnews.com/2025/06/20/fda…
China, where obesity levels are low, becomes hotbed for weight loss drug trials statnews.com/2025/06/17/wei… via @ADeAngelis_bio
Breaking: Private equity firm will finance Harvard research lab, in possible template for future statnews.com/2025/06/16/har… via @statnews @ADeAngelis_bio
RFK Jr.'s promises to Cassidy are in the spotlight: statnews.com/2025/06/10/rfk…
Several hundred NIH employees are coming together to protest many of the agency's moves in the last several months Modeled after Jay Bhattacharya's Great Barrington Declaration, they're asking him to hold true to his promise to embrace dissent statnews.com/2025/06/09/nih…